Copyright © 2008 Feikje Wesseldijk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. W. Jänig and R. Baron, “Complex regional pain syndrome: mystery explained?,” The Lancet Neurology, vol. 2, no. 11, pp. 687–697, 2003. View at Publisher · View at Google Scholar
2. M. Daemen, H. Kurvers, P. Bullens, G. Barendse, M. Van Kleef, and F. Van den Wildenberg, “Neurogenic inflammation and reflex sympathetic dystrophy (in vivo and in vitro assessment in an experimental model),” Acta Orthopaedica Belgica, vol. 64, no. 4, pp. 441–447, 1998.
3. M. A. Daemen, H. A. Kurvers, P. J. Kitslaar, D. W. Slaaf, P. H. Bullens, and F. Van den Wildenberg, “Neurogenic inflammation in an animal model of neuropathic pain,” Neurological Research, vol. 20, no. 1, pp. 41–45, 1998.
4. P. H. J. M. Veldman, H. M. Reynen, I. E. Arntz, and R. J. A. Goris, “Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients,” The Lancet, vol. 342, no. 8878, pp. 1012–1016, 1993. View at Publisher · View at Google Scholar
5. F. Birklein, B. Riedl, N. Sieweke, M. Weber, and B. Neundörfer, “Neurological findings in complex regional pain syndromes—analysis of 145 cases,” Acta Neurologica Scandinavica, vol. 101, no. 4, pp. 262–269, 2000.
6. F. Birklein, D. Claus, B. Riedl, B. Neundörfer, and H. O. Handwerker, “Effects of cutaneous histamine application in patients with sympathetic reflex dystrophy,” Muscle & Nerve, vol. 20, no. 11, pp. 1389–1395, 1997. View at Publisher · View at Google Scholar
7. F. J. P. M. Huygen, A. G. J. de Bruijn, J. Klein, and F. J. Zijlstra, “Neuroimmune alterations in the complex regional pain syndrome,” European Journal of Pharmacology, vol. 429, no. 1–3, pp. 101–113, 2001. View at Publisher · View at Google Scholar
8. G. M. Alexander, M. A. van Rijn, J. J. van Hilten, M. J. Perreault, and R. J. Schwartzman, “Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS,” Pain, vol. 116, no. 3, pp. 213–219, 2005. View at Publisher · View at Google Scholar · View at PubMed
9. F. J. P. M. Huygen, A. G. J. de Bruijn, M. T. de Bruin, J. George Groeneweg, J. Klein, and F. J. Zijlstra, “Evidence for local inflammation in complex regional pain syndrome type 1,” Mediators of Inflammation, vol. 11, no. 1, pp. 47–51, 2002. View at Publisher · View at Google Scholar · View at PubMed
10. F. Birklein, “Complex regional pain syndrome,” Journal of Neurology, vol. 252, no. 2, pp. 131–138, 2005. View at Publisher · View at Google Scholar · View at PubMed
11. R. J. Schwartzman and A. Popescu, “Reflex sympathetic dystrophy,” Current Rheumatology Reports, vol. 4, no. 2, pp. 165–169, 2002. View at Publisher · View at Google Scholar
12. F. J. P. M. Huygen, S. Niehof, F. J. Zijlstra, P. van Hagen, and P. L. A. van Daele, “Successful treatment of CRPS 1 with anti-TNF,” Journal of Pain and Symptom Management, vol. 27, no. 2, pp. 101–103, 2004. View at Publisher · View at Google Scholar
13. R. J. M. Munnikes, C. Muis, M. Boersma, C. Heijmans-Antonissen, F. J. Zijlstra, and F. J. P. M. Huygen, “Intermediate stage complex regional pain syndrome type 1 is unrelated to proinflammatory cytokines,” Mediators of Inflammation, vol. 2005, no. 6, pp. 366–372, 2005. View at Publisher · View at Google Scholar · View at PubMed
14. F. J. P. M. Huygen, N. Ramdhani, A. van Toorenenbergen, J. Klein, and F. J. Zijlstra, “Mast cells are involved in inflammatory reactions during complex regional pain syndrome type 1,” Immunology Letters, vol. 91, no. 2-3, pp. 147–154, 2004. View at Publisher · View at Google Scholar · View at PubMed
15. S. Bruehl, R. N. Harden, B. S. Galer, et al., “External validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research diagnostic criteria,” Pain, vol. 81, no. 1-2, pp. 147–154, 1999. View at Publisher · View at Google Scholar
16. A. M. Carlsson, “Assessment of chronic pain—I: aspects of the reliability and validity of the visual analogue scale,” Pain, vol. 16, no. 1, pp. 87–101, 1983. View at Publisher · View at Google Scholar
17. N. K. Lowe, S. N. Walker, and R. C. MacCallum, “Confirming the theoretical structure of the McGill pain questionnaire in acute clinical pain,” Pain, vol. 46, no. 1, pp. 53–60, 1991. View at Publisher · View at Google Scholar
18. C. Hershler, T. A. Conine, A. Nunn, and M. Hannay, “Assessment of an infra-red non-contact sensor for routine skin temperature monitoring: a preliminary study,” Journal of Medical Engineering & Technology, vol. 16, no. 3, pp. 117–122, 1992. View at Publisher · View at Google Scholar
19. M. Fereidoni, A. Ahmadiani, S. Semnanian, and M. Javan, “An accurate and simple method for measurement of paw edema,” Journal of Pharmacological and Toxicological Methods, vol. 43, no. 1, pp. 11–14, 2000. View at Publisher · View at Google Scholar
20. H. M. Oerlemans, R. A. Oostendorp, T. de Boo, L. van der Laan, J. L. Severens, and J. A. Goris, “Adjuvant physical therapy versus occupational therapy in patients with reflex sympathetic dystrophy/complex regional pain syndrome type I,” Archives of Physical Medicine and Rehabilitation, vol. 81, no. 1, pp. 49–56, 2000. View at Publisher · View at Google Scholar
21. M. A. Kemler, C. P. M. Rijks, and H. C. W. de Vet, “Which patients with chronic reflex sympathetic dystrophy are most likely to benefit from physical therapy?,” Journal of Manipulative and Physiological Therapeutics, vol. 24, no. 4, pp. 272–278, 2001. View at Publisher · View at Google Scholar · View at PubMed
22. C. Heijmans-Antonissen, F. Wesseldijk, R. J. M. Munnikes, et al., “Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1,” Mediators of Inflammation, vol. 2006, Article ID 28398, 8 pages, 2006. View at Publisher · View at Google Scholar · View at PubMed
23. E. Schmidt, B. Bastian, R. Dummer, H.-P. Tony, E.-B. Bröcker, and D. Zillikens, “Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid,” Archives of Dermatological Research, vol. 288, no. 7, pp. 353–357, 1996. View at Publisher · View at Google Scholar
24. F. Wesseldijk, F. J. Huygen, C. Heijmans-Antonissen, S. Niehof, and F. J. Zijlstra, “Tumor necrosis factor-$\alpha$ and interleukin-6 are not correlated with the characteristics of complex regional pain syndrome type 1 in 66 patients,” European Journal of Pain. In press. View at Publisher · View at Google Scholar · View at PubMed
25. M. Vaneker, O. H. G. Wilder-Smith, P. Schrombges, I. de Man-Hermsen, and H. M. Oerlemans, “Patients initially diagnosed as ‘warm’ or ‘cold’ CRPS 1 show differences in central sensory processing some eight years after diagnosis: a quantitative sensory testing study,” Pain, vol. 115, no. 1-2, pp. 204–211, 2005. View at Publisher · View at Google Scholar · View at PubMed
26. M. Vaneker, O. H. G. Wilder-Smith, P. Schrombges, and H. M. Oerlemans, “Impairments as measured by ISS do not greatly change between one and eight years after CRPS 1 diagnosis,” European Journal of Pain, vol. 10, no. 7, pp. 639–644, 2006. View at Publisher · View at Google Scholar · View at PubMed
27. G. Wasner, K. Heckmann, C. Maier, and R. Baron, “Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I): complete inhibition of sympathetic nerve activity with recovery,” Archives of Neurology, vol. 56, no. 5, pp. 613–620, 1999. View at Publisher · View at Google Scholar
28. G. Wasner, J. Schattschneider, K. Heckmann, C. Maier, and R. Baron, “Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value,” Brain, vol. 124, no. 3, pp. 587–599, 2001.
29. S. P. Niehof, F. J. P. M. Huygen, R. W. P. van der Weerd, M. Westra, and F. J. Zijlstra, “Thermography imaging during static and controlled thermoregulation in complex regional pain syndrome type 1: diagnostic value and involvement of the central sympathetic system,” BioMedical Engineering Online, vol. 5, article 30, pp. 1–13, 2006. View at Publisher · View at Google Scholar · View at PubMed
30. J. George Groeneweg, F. J. P. M. Huygen, C. Heijmans-Antonissen, S. Niehof, and F. J. Zijlstra, “Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1,” BMC Musculoskeletal Disorders, vol. 7, article 91, pp. 1–8, 2006. View at Publisher · View at Google Scholar · View at PubMed
31. F. J. P. M. Huygen, S. Niehof, J. Klein, and F. J. Zijlstra, “Computer-assisted skin videothermography is a highly sensitive quality tool in the diagnosis and monitoring of complex regional pain syndrome type 1,” European Journal of Applied Physiology, vol. 91, no. 5-6, pp. 516–524, 2004. View at Publisher · View at Google Scholar · View at PubMed
32. G. Gradl, B. Finke, S. Schattner, P. Gierer, T. Mittlmeier, and B. Vollmar, “Continuous intra-arterial application of substance P induces signs and symptoms of experimental complex regional pain syndrome (CRPS) such as edema, inflammation and mechanical pain but no thermal pain,” Neuroscience, vol. 148, no. 3, pp. 757–765, 2007. View at Publisher · View at Google Scholar · View at PubMed
33. S. Leis, M. Weber, M. Schmelz, and F. Birklein, “Facilitated neurogenic inflammation in unaffected limbs of patients with complex regional pain syndrome,” Neuroscience Letters, vol. 359, no. 3, pp. 163–166, 2004. View at Publisher · View at Google Scholar · View at PubMed
34. F. Wesseldijk, D. Fekkes, F. J. P. M. Huygen, M. van de Heide-Mulder, and F. J. Zijlstra, “Increased plasma glutamate, glycine, and arginine levels in complex regional pain syndrome type 1,” Acta Anaesthesiologica Scandinavica, vol. 52, no. 5, pp. 688–694, 2008.
35. F. Wesseldijk, D. Fekkes, F. J. Huygen, E. Bogaerts-Taal, and F. J. Zijlstra, “Increased plasma serotonin in complex regional pain syndrome type 1,” Anesthesia & Analgesia, vol. 106, no. 6, pp. 1862–1867, 2008. View at Publisher · View at Google Scholar · View at PubMed